MANKIND — Mankind Pharma Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual cashflow statement for Mankind Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	14,377	16,916	19,746	16,712	23,994
Depreciation
Non-Cash Items	90.5	-1,246	-1,358	-275	-1,860
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-4,761	-5,487	-10,856	-1,564	-4,591
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	10,697	11,372	9,198	18,133	21,524
Capital Expenditures	-2,280	-3,123	-23,455	-8,321	-3,892
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-2,112	-9,099	9,764	-2,221	-16,925
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-4,392	-12,222	-13,691	-10,541	-20,817
Financing Cash Flow Items	-3,862	-1,172	-178	-419	-262
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities	-5,307	-78.1	6,046	-7,397	52.7
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	1,034	-924	1,557	218	772